Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590473 · ClinicalTrials.gov registry record · NA
Sacral Neuromodulation in Patients With IC
A NA study, sponsored by Drexel University College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT00590473 is a NA study that has completed, run by Drexel University College of Medicine. The registered enrollment target is 32 participants.
The verdict
NCT00590473, a NA study, has completed, sponsored by Drexel University College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The hypothesis for this study is that bilateral sacral neuromodulation will improve symptoms of interstitial cystitis by at least 25% when compared to unilateral sacral neuromodulation as reported by patient's responses to the Interstitial Cystitis Symptom and Problem Indices. This study will be a prospective randomized study comparing bilateral to unilateral sacral neuromodulation. The study population will include all patients diagnosed with interstitial cystitis, using the NIDDK criteria, having staged sacral neuromodulator stimulators placed at Hahnemann University Hospital.
Interventions
- DEVICE Interstim
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00590473
The ClinicalTrials.gov registry entry for NCT00590473 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University College of Medicine, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Interstim is the first listed.
NCT00590473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00590473 about?
NCT00590473 is a clinical study titled "Sacral Neuromodulation in Patients With IC". The hypothesis for this study is that bilateral sacral neuromodulation will improve symptoms of interstitial cystitis by at least 25% when compared to unilateral sacral neuromodulation as reported by patient's responses to the Interstitial Cystitis Symptom and Problem Indices. This study will be a ...
What is the current status of trial NCT00590473?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2007-04. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00590473?
The interventions under investigation include: Interstim (DEVICE).
Who is sponsoring clinical trial NCT00590473?
This trial is sponsored by Drexel University College of Medicine, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.